Sands Capital Life Sciences Pulse Fund II, L.P.
10% Owner
FundBuying only
- 2025
- Nov 24, 2025
- 1
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Sands Capital Life Sciences Pulse Fund II, L.P.. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Roberto Bellini - $2.00M in IKT purchases and sales on record
- Amit Munshi - $500K in IKT purchases and sales on record
- Arvind Kush - $199K in IKT purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Sands Capital Life Sciences Pulse Fund II, L.P.?
Sands Capital Life Sciences Pulse Fund II, L.P. is an investment firm, tracked as 10% Owner of Inhibikase Therapeutics, Inc. (IKT). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sands Capital Life Sciences Pulse Fund II, L.P. last file a Form 4?
The only primary Form 4 on record is dated 24 November 2025.
Has Sands Capital Life Sciences Pulse Fund II, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($3.00M) and 0 open-market sales across all tracked filings.
